drugset / Trial / NCT03289481

Treatment of HFpEF With Nitrate Supplement

NCT03289481 ↗

Phase 0 Completed 13 enrolled MaineHealth HumanN · collab
RandomizedCrossoverQuadruple-blindTreatment

Summary

The objective of this project is to determine if Neo40, a nitric oxide generating lozenge, when consumed twice daily by subjects with HFpEF, will increase exercise tolerance, decrease symptoms and improve quality of life for patients.

Timeline

Start
2017-06-29
Primary completion
2018-08-22
Completion
2018-08-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Beetroot Juice Other / unclassified — Oral